Although the primary mechanism of QTc prolongation/TdP is known to be hERG blockade, many risk factors can contribute, such as KCNH2 gene mutation, electrolyte disturbances, pre‐existing heart disease, bradycardia, or gender.29, 30. This evidence concerns the gene KCNH2 and heart disorder.